Kezar Life Sciences Inc.
6.44
0.23 (3.70%)
At close: Jan 15, 2025, 11:17 AM

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
Revenue 7.00M n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue 1.07M 1.02M 1.51M 1.54M 1.30M 690.00K 175.00K 154.00K
Gross Profit 5.93M -1.02M -1.51M -1.54M -1.30M -690.00K -175.00K -154.00K
Operating Income -105.24M -71.16M -54.66M -42.95M -37.34M -24.73M -8.75M -8.99M
Interest Income 11.10M 4.11M 188.00K 1.21M 2.25M 1.56M 232.00K n/a
Pretax Income -101.87M -68.24M -54.63M -41.74M -35.09M -23.17M -8.52M -8.99M
Net Income -101.87M -65.32M -53.28M -38.99M -31.53M -23.17M -8.52M -8.99M
Selling & General & Admin 26.54M 20.15M 15.72M 11.97M 9.98M 6.59M 2.28M 1.62M
Research & Development 85.70M 51.01M 38.94M 30.98M 27.36M 18.14M 6.47M 7.37M
Other Expenses 6.19M n/a n/a n/a n/a n/a n/a n/a
Operating Expenses 118.42M 71.16M 54.66M 42.95M 37.34M 24.73M 8.75M 8.99M
Interest Expense 1.55M 1.19M 159.00K n/a n/a n/a n/a n/a
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses 112.24M 71.16M 54.66M 42.95M 37.34M 24.73M 8.75M 8.99M
Income Tax n/a -2.92M -1.35M -2.75M -3.56M 1.56M n/a n/a
Shares Outstanding (Basic) 72.55M 67.37M 52.76M 44.00M 19.08M 10.26M 13.02M 13.02M
Shares Outstanding (Diluted) 72.55M 67.37M 52.76M 44.00M 19.08M 10.26M 13.02M 13.02M
EPS (Basic) -1.4 -0.97 -1.01 -0.89 -1.65 -2.26 -0.65 -0.69
EPS (Diluted) -1.4 -0.97 -1.01 -0.89 -1.65 -2.26 -0.65 -0.69
EBITDA -99.25M -66.11M -52.96M -40.26M -34.42M -22.48M -8.34M -8.84M
Depreciation & Amortization 1.07M 1.02M 1.51M 1.54M 1.30M 690.00K 175.00K 154.00K